Bruce C. Cozadd
2008
In 2008, Bruce C. Cozadd earned a total compensation of $915.2K as Chairman and Chief Executive Officer at Jazz Pharmaceuticals, a 18% decrease compared to previous year.
Compensation breakdown
| Option Awards | $490,241 |
|---|---|
| Salary | $423,523 |
| Other | $1,435 |
| Total | $915,199 |
Cozadd received $490.2K in option awards, accounting for 54% of the total pay in 2008.
Cozadd also received $423.5K in salary and $1.4K in other compensation.
Rankings
In 2008, Bruce C. Cozadd's compensation ranked 4,666th out of 9,135 executives tracked by ExecPay. In other words, Cozadd earned more than 48.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,666 out of 9,135 | 49th |
Division Manufacturing | 1,678 out of 3,436 | 51st |
Major group Chemicals And Allied Products | 332 out of 815 | 59th |
Industry group Drugs | 199 out of 597 | 67th |
Industry Pharmaceutical Preparations | 146 out of 408 | 64th |
Source: SEC filing on April 16, 2010.
Cozadd's colleagues
We found four more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2008.
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019